期刊文献+

儿童急性白血病骨髓细胞中血管内皮生长因子及其受体的表达 被引量:1

The expressions of vascular endothelial growth factor(VEGF) and its receptors KDR and Flt-1 in bone marrow of children with acute leukemia
原文传递
导出
摘要 目的探讨血管内皮生长因子(VEGF)及其受体(VEGFR)在儿童急性白血病(AL)患者骨髓中的表达,分析其在化疗前后的变化。方法采用免疫组化S-P法检测53例AL患儿治疗前后以及对照组骨髓中VEGF/VEGFR(包括Flt-1和KDR两种)变化,分析其与临床特征的关系。结果VEGF,Flt-1,KDR在AL患儿骨髓中表达水平高于对照组。VEGF,Flt-1,KDR的表达于化疗达完全缓解(CR)后下调;化疗后未获得CR患儿VEGF,Flt-1,KDR的表达在化疗前后差异无统计学意义。骨髓中VEGF,Flt-1,KDR的表达水平在不同年龄、性别、有无髓外浸润间差异无统计学意义。结论VEGF,Flt-1,KDR在儿童AL中呈高表达,化疗后表达明显降低,说明VEGF可以作为评价儿童AL化疗反应的指标。 Objective To investigate the expressions of VEGF/VEGFR in bone marrow of children with acute leukemia, and to observe changes before and after chemotherapy. Methods The bone marrows of 53 children with acute leukemia were assayed to study the expression of VEGF/VEGFR(KDR, Flt-1 )before and after chemotherapy with S-P immonohistochemical staining. Their relations to the clinical features were evaluated. Results The expressions of VEGF, Flt-1, KDR were significantly higher in newly diagnosed children with tha...
出处 《白血病.淋巴瘤》 CAS 2006年第4期255-256,259,共3页 Journal of Leukemia & Lymphoma
基金 河南省教育厅资助课题(20023200004)
  • 相关文献

参考文献2

二级参考文献20

  • 1Lin P,Sankar S,Shan S,et al.Inhibition of tumor growth by targeting tunor endothelium using a soluble vascular endothelial growth factor receptor[ J ].Cell Growth Differ,1998,9 (1):49-58. 被引量:1
  • 2Foss HD,Araujo I,Demel G,et al.Expression of vascular endothelial growth factor in lymphomas and Castleman's disease [ J ].J Pathol,1997,183 (1):44-50. 被引量:1
  • 3Salven P,Teerenhovi L,Joensuu H.A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphona [ J ].Blood,1997,90 (8):3167-3172. 被引量:1
  • 4Podar K,Tai YT,Davies FE,et al.Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration [ J ].Blood,2001,98 (2):428-435. 被引量:1
  • 5Sezer O,Jakob C,Eucker J,et al.Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF),vascular endothelial growth factor(VEGF) and hepatocyte growth factor(HGF) in multiple myeloma [ J ].Eur J Haemato1,2001,66 (2): 83-88. 被引量:1
  • 6Zorat F,Shetty V,Dutt D,et al.The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes [ J ],Br J Haemato1,2001,115 (4):881 - 894. 被引量:1
  • 7Bertolini F,Mingrone W,Alietti A,et al.Thalidomide in multiple myeloma,myelodysplastic syndromes and histiocytosis.Analysis of clinical results and of surrogate angiogenesis markers [ J ].Ann Oncol ,2001,12 (7):987-990. 被引量:1
  • 8de Bont ES,Rosati S,Jacobs S,et al.Increased bone marrow vascularization in patients with acute myeloid leukaemia:a possible role for vascular endothelial growth factor[ J ].Br J Haematol,2001,113(2):296-304. 被引量:1
  • 9Kini AR,Peterson LA,Tallman MS,et al.Angiogenesis in acute promyelocytic leukemia:induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid[ J ].Blood ,2001,97 (12):3919-3924. 被引量:1
  • 10Fiedler W,Graeven U,Ergun S,et al.Vascular endothelial growth factor,a possible paracrine growth factor in human acute myeloid leukemia [ J ].Blood,1997,89 (6): 1870 -1875. 被引量:1

共引文献3

同被引文献30

  • 1李锋,陈朴,邹善华.慢性髓细胞性白血病与血管生成因子关系[J].中国癌症杂志,2004,14(5):462-465. 被引量:4
  • 2Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with lymphoblastic leukemia. Am J Pathol, 1997, 150: 815-821. 被引量:1
  • 3Negaard HF, Iversen N, Bowitz-Lothe IM, et al. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors. Leukemia, 2009, 23:162-169. 被引量:1
  • 4Ding Y, Zhu X, Li Y, et al. Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). Hematology, 2012, 17: 157-162. 被引量:1
  • 5Welm B, Mott J, Werb Z. Developmental biology: vasculogenesis is a wreck without RECK. Curr Biol, 2002, 12:209-211. 被引量:1
  • 6Koomagi R, Zintl F, Sauerbrey A, et al. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res, 2001, 7:3381-3384. 被引量:1
  • 7Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in .acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000, 96: 2240-2245. 被引量:1
  • 8Wang L, Shi WY, Yang F, et al. Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells. Haematologica, 2011,96:927-931. 被引量:1
  • 9Zhu Z, Hattori K, Zhang H, et al. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Leukemia, 2003, 17:604-611. 被引量:1
  • 10Dias S, Hattori K, Heissig B, et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A. 2001, 98: 10857-10862. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部